Burns-Hamuro Lora L, Dalessio Paula M, Ropson Ira J
Department of Biochemistry and Molecular Biology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, USA.
Protein Sci. 2004 Jun;13(6):1670-6. doi: 10.1110/ps.03317804.
Site-directed mutagenesis has frequently been used to replace proline with other amino acids in order to determine if proline isomerization is responsible for a slow phase during refolding. Replacement of Pro 85 with alanine in cellular retinoic acid binding protein I (CRABP-I) abolished the slowest refolding phase, suggesting that this phase is due to proline isomerization in the unfolded state. To further test this assumption, we mutated Pro 85 to valine, which is the conservative replacement in the two most closely related proteins in the family (cellular retinoic acid binding protein II and cellular retinol binding protein I). The mutant protein was about 1 kcal/mole more stable than wild type. Retinoic acid bound equally well to wild type and P85V-CRABP I, confirming the functional integrity of this mutation. The refolding and unfolding kinetics of the wild-type and mutant proteins were characterized by stopped flow fluorescence and circular dichroism. The mutant P85V protein refolded with three kinetic transitions, the same number as wild-type protein. This result conflicts with the P85A mutant, which lost the slowest refolding rate. The P85V mutation also lacked a kinetic unfolding intermediate found for wild-type protein. These data suggest that proline isomerization may not be responsible for the slowest folding phase of CRABP I. As such, the loss of a slow refolding phase upon mutation of a proline residue may not be diagnostic for proline isomerization effects on protein folding.
定点诱变经常被用于用其他氨基酸取代脯氨酸,以确定脯氨酸异构化是否是重折叠过程中慢相的原因。在细胞视黄酸结合蛋白I(CRABP-I)中,将Pro 85替换为丙氨酸消除了最慢的重折叠相,这表明该相是由于未折叠状态下的脯氨酸异构化所致。为了进一步验证这一假设,我们将Pro 85突变为缬氨酸,缬氨酸是该家族中两个最密切相关的蛋白质(细胞视黄酸结合蛋白II和细胞视黄醇结合蛋白I)中的保守替换氨基酸。突变蛋白比野生型稳定约1千卡/摩尔。视黄酸与野生型和P85V-CRABP I的结合效果相同,证实了该突变的功能完整性。通过停流荧光和圆二色性对野生型和突变蛋白的重折叠和去折叠动力学进行了表征。突变的P85V蛋白以三个动力学转变进行重折叠,与野生型蛋白的数量相同。这一结果与P85A突变体不同,P85A突变体失去了最慢的重折叠速率。P85V突变体也没有野生型蛋白所具有的动力学去折叠中间体。这些数据表明,脯氨酸异构化可能不是CRABP I最慢折叠相的原因。因此,脯氨酸残基突变后慢重折叠相的丧失可能无法诊断脯氨酸异构化对蛋白质折叠的影响。